Scientists have come up with a treatment to fight endometrial and ovarian cancer using “super sticky” bio-adhesive nanoparticles laced with chemotherapy drugs.
A new study published in the Lancet, the original study focused on the benefits of oral birth control.
Before we go into the findings let’s make clear what exactly the BRCA gene is: First of all BRCA genes – BRCA1 & BRCA2 are not the culprits here, the “mutation” of these genes is the villain.
With many cancer rates going down, there has been an up-tic in in uterine cancer diagnoses; in particular uterine cancer is hitting African-American women hard, at rates current higher than 80% than Caucasian women.
Increased risk for aggressive serous/serous-like endometrial cancer was increased in women with BRCA1 mutations, although the overall risk for uterine cancer after risk-reducing salpingo-oophorectomy (RRSO) to remove the fallopian tube and ovary was not increased, according to a new study published online by JAMA Oncology.